Covista screens attractively valued at a forward P/E of 13.2 times and a PEG of 0.88, underpinned by four consecutive earnings beats averaging more than 11% above consensus; the chief offset is negative price momentum that has not cleared the minimum threshold, keeping the entry setup cautious despite sound fundamentals.
Thesis pillars
- Negative Momentum Near Term Headwind→Stable
- Attractive Forward Valuation Low Peg→Stable
- Solid Piotroski Financial Health→Stable
- +1 more pillar — see the Why tab for full reasoning
Covista Inc. (CVSA) Stock Analysis
Breakout setup
Consumer Defensive · Education & Training Services
Sell if holding. Analyst target reached at $129.88 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak growth.
Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make... Read more
Sell if holding. Analyst target reached at $129.88 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak growth. Chart setup: Golden cross, above all MAs, RSI 47, MACD bullish. Score 5.2/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 34d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-07-06Recent Developments — Covista Inc.
Latest news
- NEWS CVSA Covista posts 8.9 percent Q1 2026 earnings per share beat, shares rise 1.29 percent today. - Top Analyst Buy Signal — Newser positive
- NEWS CVSA Covista posts 8.9 percent Q1 2026 earnings per share beat, shares rise 1.29 percent today. - Expert Verified Trades — Newser positive
- NEWS Here's why Covista (CVSA) is a strong value stock - MSN — MSN positive
- NEWS Here's Why Covista (CVSA) is a Strong Value Stock - Yahoo Finance — Yahoo Finance positive
- NEWS Earnings To Watch: Covista (CVSA) Reports Q1 Results Tomorrow - StockStory — StockStory neutral
Generated 2026-07-06T06:30:27Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $129.88 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Weak growth. Chart setup: Golden cross, above all MAs, RSI 47, MACD bullish. Prior stop was $120.79. Score 5.2/10, moderate confidence.
Take-profit target: $132.81 (+2.3% upside). Prior stop was $120.79. Stop-loss: $120.79.
Analyst target reached - limited upside remaining; Weak growth.
Covista Inc. trades at a P/E of 18.9 (forward 14.6). TrendMatrix value score: 6.9/10. Verdict: Sell.
10 analysts cover CVSA with a consensus score of 4.3/5. Average price target: $156.
What does Covista Inc. do?Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse...
Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make inspiring contributions to our global community.